Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-41.65%
operating margin TTM
-35.84%
revenue TTM
593.62 Million
revenue per share TTM
16.22$
valuation ratios | |
|---|---|
| pe ratio | -0.03 |
| peg ratio | -0.00 |
| price to book ratio | -0.15 |
| price to sales ratio | 0.02 |
| enterprise value multiple | 0.58 |
| price fair value | -0.15 |
profitability ratios | |
|---|---|
| gross profit margin | 33.01% |
| operating profit margin | -35.84% |
| pretax profit margin | -41.56% |
| net profit margin | -41.65% |
| return on assets | -62.65% |
| return on equity | 12267.09% |
| return on capital employed | 3087.66% |
liquidity ratio | |
|---|---|
| current ratio | 0.71 |
| quick ratio | 0.36 |
| cash ratio | 0.17 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 128.88 |
| operating cycle | 167.22 |
| days of payables outstanding | 64.90 |
| cash conversion cycle | 102.32 |
| receivables turnover | 9.52 |
| payables turnover | 5.62 |
| inventory turnover | 2.83 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.44 |
| debt equity ratio | -3.10 |
| long term debt to capitalization | -0.04 |
| total debt to capitalization | 1.48 |
| interest coverage | -6.86 |
| cash flow to debt ratio | -0.86 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.36 |
| cash per share | 0.16 |
| operating cash flow per share | -0.35 |
| free cash flow operating cash flow ratio | 1.03 |
| cash flow coverage ratios | -0.86 |
| short term coverage ratios | -0.87 |
| capital expenditure coverage ratio | -31.45 |
Frequently Asked Questions
When was the last time BIOLASE, Inc. (NASDAQ:BIOL) reported earnings?
BIOLASE, Inc. (BIOL) published its most recent earnings results on 08-08-2024.
What is BIOLASE, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. BIOLASE, Inc. (NASDAQ:BIOL)'s trailing twelve months ROE is 12267.09%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. BIOLASE, Inc. (BIOL) currently has a ROA of -62.65%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BIOL's net profit margin stand at?
BIOL reported a profit margin of -41.65% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BIOL's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.71 in the most recent quarter. The quick ratio stood at 0.36, with a Debt/Eq ratio of -3.10.